Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 126


Addition of Partial Envelope Domain II into Envelope Domain III of Dengue Virus Antigen Potentiates the Induction of Virus-Neutralizing Antibodies and Induces Protective Immunity.

Park J, Lee HY, Khai LT, Thuy NTT, Mai LQ, Jang YS.

Vaccines (Basel). 2020 Feb 15;8(1). pii: E88. doi: 10.3390/vaccines8010088.


Silk peptide treatment potentiates natural killer cell activity in vitro and induces natural killer cell maturation and activation in mouse splenocytes.

Jang SH, Oh MS, Baek HI, Ha KC, Lee JY, Jang YS.

Pharm Biol. 2019 Dec;57(1):369-379. doi: 10.1080/13880209.2019.1617749.


Human β-defensin 2 is involved in CCR2-mediated Nod2 signal transduction, leading to activation of the innate immune response in macrophages.

Kim J, Yang YL, Jang YS.

Immunobiology. 2019 Jul;224(4):502-510. doi: 10.1016/j.imbio.2019.05.004. Epub 2019 May 18.


Expression, Purification, and in vivo Evaluation of GFP-Fused M Cell Targeting Receptor Binding Domain of Protein FimH.

Nguyen-Thi TH, Huynh KQ, Dinh-Thi PL, Tran LT, Jang YS, Tran-Van H.

Protein Pept Lett. 2019;26(9):676-683. doi: 10.2174/0929866526666190405122805.


Glycoproteins isolated from Atractylodes macrocephala Koidz improve protective immune response induction in a mouse model.

Kim KA, Son YO, Kim SS, Jang YS, Baek YH, Kim CC, Lee JH, Lee JC.

Food Sci Biotechnol. 2018 Jul 10;27(6):1823-1831. doi: 10.1007/s10068-018-0430-1. eCollection 2018 Dec.


Oral Administration of Silk Peptide Enhances the Maturation and Cytolytic Activity of Natural Killer Cells.

Jang SH, Oh MS, Baek HI, Ha KC, Lee JY, Jang YS.

Immune Netw. 2018 Oct 26;18(5):e37. doi: 10.4110/in.2018.18.e37. eCollection 2018 Oct.


Evaluation of cell-surface displayed synthetic consensus dengue EDIII cells as a potent oral vaccine candidate.

Bal J, Jung HY, Nguyen LN, Park J, Jang YS, Kim DH.

Microb Cell Fact. 2018 Sep 14;17(1):146. doi: 10.1186/s12934-018-0994-8.


N-terminal Domain of the Spike Protein of Porcine Epidemic Diarrhea Virus as a New Candidate Molecule for a Mucosal Vaccine.

Kim SH, Cho BH, Lee KY, Jang YS.

Immune Netw. 2018 Jun 15;18(3):e21. doi: 10.4110/in.2018.18.e21. eCollection 2018 Jun.


Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate.

Bal J, Luong NN, Park J, Song KD, Jang YS, Kim DH.

Microb Cell Fact. 2018 Feb 16;17(1):24. doi: 10.1186/s12934-018-0876-0.


C5a receptor targeting of partial non-structural protein 3 of dengue virus promotes antigen-specific IFN-γ-producing T-cell responses in a mucosal dengue vaccine model.

Kim SH, Kim YN, Kim J, Jang YS.

Cell Immunol. 2018 Mar;325:41-47. doi: 10.1016/j.cellimm.2018.01.016. Epub 2018 Feb 15.


Heterogeneous Nuclear Ribonucleoprotein A2B1 Exerts a Regulatory Role in Lipopolysaccharide-stimulated 38B9 B Cell Activation.

Park J, Choe CH, Kim J, Yang JS, Kim JH, Jang H, Jang YS.

Immune Netw. 2017 Dec;17(6):437-450. doi: 10.4110/in.2017.17.6.437. Epub 2017 Dec 19.


Plant-expressed Fc-fusion protein tetravalent dengue vaccine with inherent adjuvant properties.

Kim MY, Copland A, Nayak K, Chandele A, Ahmed MS, Zhang Q, Diogo GR, Paul MJ, Hofmann S, Yang MS, Jang YS, Ma JK, Reljic R.

Plant Biotechnol J. 2018 Jul;16(7):1283-1294. doi: 10.1111/pbi.12869. Epub 2018 Feb 1.


Microbiota-derived butyrate suppresses group 3 innate lymphoid cells in terminal ileal Peyer's patches.

Kim SH, Cho BH, Kiyono H, Jang YS.

Sci Rep. 2017 Jun 21;7(1):3980. doi: 10.1038/s41598-017-02729-6.


Molecular engineering and plant expression of an immunoglobulin heavy chain scaffold for delivery of a dengue vaccine candidate.

Kim MY, Van Dolleweerd C, Copland A, Paul MJ, Hofmann S, Webster GR, Julik E, Ceballos-Olvera I, Reyes-Del Valle J, Yang MS, Jang YS, Reljic R, Ma JK.

Plant Biotechnol J. 2017 Dec;15(12):1590-1601. doi: 10.1111/pbi.12741. Epub 2017 Jul 15.


Oral administration of red ginseng powder fermented with probiotic alleviates the severity of dextran-sulfate sodium-induced colitis in a mouse model.

Jang SH, Park J, Kim SH, Choi KM, Ko ES, Cha JD, Lee YR, Jang H, Jang YS.

Chin J Nat Med. 2017 Mar;15(3):192-201. doi: 10.1016/S1875-5364(17)30035-3.


The development of mucosal vaccines for both mucosal and systemic immune induction and the roles played by adjuvants.

Kim SH, Jang YS.

Clin Exp Vaccine Res. 2017 Jan;6(1):15-21. doi: 10.7774/cevr.2017.6.1.15. Epub 2017 Jan 25. Review.


Fucoidan inhibits LPS-induced inflammation in vitro and during the acute response in vivo.

Park J, Cha JD, Choi KM, Lee KY, Han KM, Jang YS.

Int Immunopharmacol. 2017 Feb;43:91-98. doi: 10.1016/j.intimp.2016.12.006. Epub 2016 Dec 14.


Supplemental Content

Loading ...
Support Center